Focus: 71st AACC Annual Scientific Meeting & Clinical Lab Expo

• share
• favorite_border

AACC welcomed thousands of medical professionals and healthcare leaders to the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo from July 24-28. The meeting featured groundbreaking diagnostic advances that will solve challenging patient health problems, and affirmed just how essential laboratory medicine professionals are to patient safety and care.

• share
• favorite_border

The 2023 EuroMedLab Congress will feature innovative and diverse education opportunities, including lectures, symposia, recent advancements in clinical practice and science, poster presentations, and industry exhibits, as well as an excellent social program

• share
• favorite_border

In 70 years, Laboratory Medicine underwent many changes, incorporating the concept of P6 medicine (Personalised, Predictive, Preventive, Participatory, Psychocognitive, Public), a model of highly participatory, interactive,“augmented” lab med to better interact with health professionals and patients

• share
• favorite_border

Faster mobile PCR test device helping business continuity

• share
• favorite_border

Taiwan Excellence Pavilion is honored to have Chroma ATE Inc., Taiwan Advanced Nanotech, CYP (Cypress Technology), :dc (Dacian Technology), and IDRC (CHYNG HONG ELECTRONIC CO. LTD.) representing Taiwan to showcase their phenomenal innovations starting on the 26th of this month. It is estimated to attract over 20 thousand visiting practitioners from affiliated fields to attend and proceed with further discussions in business over the 3-day AACC expo.

• share
• favorite_border

DIFF-Line™ by CellaVision is a new, comprehensive solution for small labs. It consists of three instruments for smearing, staining, and analyzing peripheral blood smears: CellaVision® DC-1, RAL® SmearBox, and RAL® StainBox.

• share
• favorite_border

Vircell, leading provider of independent external run controls for nucleic acid testing, announces the launch of a new independent molecular control which will help laboratories all over the world to combat the current outbreak

• share
• favorite_border

The Call For Study Proposals Strategic Objectives are: 1) To promote directed research evaluating the role of lab medicine on clinical outcomes 2) To build awareness and understanding on the critical role of lab medicine plays in healthcare outcomes. Terms and conditions for the Grant are described.

• share
• favorite_border

Linxens, a global expert in the manufacture of micro-connectors for smart cards and RFID antennas, announces that their electrodes are a cost-effective & high-quality alternative to standard gold electrodes.

• share
• favorite_border

Tesi Group will exhibit at the AACC Annual Scientific Meeting & Clinical Lab Expo alongside GPI USA, joined by Italian parent company Gpi Group, following up on an agreement recently signed by the two parties for the acquisition at the end of Q3 of 65% of the share capital of TESI by Gpi Group.

• share
• favorite_border

ZeptoMetrix®, an Antylia Scientific™ company, today launches the NATtrol™ Bacteriophage MS2 quantitative stock: NATMS2-STQ. This product is intended for use as an internal process control for molecular diagnostic assays.

• share
• favorite_border

The Georgia Department of Economic Development announced the winners of their annual Globe Awards on May 23rd, 2022. Among the awards were three top designations for Exporter of the Year. Athens Research and Technology, Inc. (ART) was the recipient of the Exporter of the Year award for a business with less than 20 employees. The award was presented at the laboratory to ART's CEO, John Mitchell, on May 25th by Mary Waters, the Deputy Commissioner of International Trade for the State of Georgia.

• share
• favorite_border

As the cannabis derivative delta-8-THC grows in popularity, it’s important for drug tests to be able to detect and differentiate it from delta-9-THC—the primary psychoactive ingredient in cannabis. Breaking research showcased at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo demonstrates that common drug testing methods can do just that.

• share
• favorite_border

New research shows that removing a race modifier from a formula used to diagnose kidney disease could lead to more equitable care for Black patients. This study and a second that examines how this same diagnostic approach impacts Asian patients will be presented at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo.

• share
• favorite_border

Two studies presented today at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo reveal how SARS-CoV-2 antibody levels vary among recipients of COVID-19 vaccines and naturally infected individuals. These findings add to a growing body of knowledge that is essential for guiding public health initiatives, and that might one day enable clinicians to assess individuals’ immunity to SARS-CoV-2.

• share
• favorite_border

A first-of-its-kind test could make it easier for newborns to get care for spinal muscular atrophy, a common genetic disease that is life-threatening but treatable if caught in time. Findings on this method and a second innovative test that could improve diagnosis of pediatric urinary tract infections (UTIs) will be discussed today at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo.

• share
• favorite_border

Scientists have developed a cheap, convenient smartphone test for monitoring patients at risk for dangerous blood clots. Research demonstrating that this test works, along with a second study on using artificial intelligence (AI) to improve testing and treatment for people with kidney stones, will be presented at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo. Both studies could help resolve longstanding challenges in healthcare and laboratory testing.

• share
• favorite_border

AACC is pleased to announce the winners of its 2022 Top Corporate Supporter Awards. This year, AACC recognizes 35 different companies and organizations that generously support the association through advertising, sponsorships, and exhibiting. These significant contributions make it possible for AACC to further its mission of better health through laboratory medicine.

• share
• favorite_border

ZeptoMetrix®, an Antylia Scientific™ company, today launches its new external run control for Flu, RSV, SARS-CoV-2: NATFRC-ERC. This third-party molecular quality control can be used by laboratories to monitor the continued performance of their multiplexed respiratory assays. It is available for pre-order.

• share
• favorite_border

The IFCC Distinguished Awards are bestowed to laboratory medicine professionals to recognize their outstanding achievements, publicize their exceptional research and contributions to medicine and healthcare, and encourage the overall advancement of clinical chemistry and laboratory medicine.

• share
• favorite_border

LumiraDx, a next-generation point of care diagnostics company will be hosting an industry workshop at this week’s American Association for Clinical Chemistry (AACC) Annual Conference in Chicago. The workshop, held on July 27th, will include data-backed insights on the impact of LumiraDx’s advanced microfluidic technology over lateral flow point-of-care antigen tests, and the role of these rapid immunoassays in response to the COVID-19 pandemic.

• share
• favorite_border

Cytovale®, a medical diagnostics company focused on providing rapid and insightful tools to improve early detection of fast-moving and immune-mediated diseases, will reveal its 510(k) pending Cytovale system and 10-minute IntelliSep® sepsis risk stratification test at the American Association for Clinical Chemistry (AACC) annual meeting, where new data featuring the test will also be shared. The instrument can be seen in the Cytovale booth, no. 5045, in the exhibit hall during Clinical Lab Expo hours. The IntelliSep test was recently named an AACC Disruptive Technology Award Semifinalist and is also being featured in the Disruptive Tech area of the exhibit hall during the meeting.

• share
• favorite_border

BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, today announced the launch of its digital Connected Diagnostics Platform at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo. This comprehensive, end-to-end platform is a one-stop shop for in vitro diagnostics manufacturers that streamlines workflows, accelerates revenue growth and drives innovation.

• share
• favorite_border

Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex workflows for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs liberates genomics to deliver increased clarity. Clear Labs’ turnkey platform accelerates outcomes and improves accuracy for detection and surveillance of infectious diseases. With a novel approach, Clear Labs is helping the world better understand, track and mitigate tomorrow’s novel pathogens.

• share
• favorite_border

At the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care.

• share
• favorite_border

Rhinostics introduces another breakthrough in automated sample collection technologies with the launch of the patent-pending VERIstic™ Collection Device focused on small volume blood collection.

• share
• favorite_border

New Product Announcement

• share
• favorite_border

Techcyte and Cytobay are proud to announce their collaboration in the creation of a non-invasive test that will redefine bladder cancer surveillance.

• share
• favorite_border

Techcyte, a leading developer of AI-based image analysis solutions for the diagnostics industry, is proud to announce the release of their second-generation solution for Human Fecal Trichrome (HFT) for human parasites.

• share
• favorite_border

A study authored by researchers at Quest Diagnostics and presented at ASM Microbe on June 9-12th 2022 in Washington, D.C. provides evidence that the Techcyte technology aids in the detection of intestinal protozoa.

• share
• favorite_border

Specifically designed to support the Sysmex® XN-Series hematology line, AutoSorter™ XN is a robust robotic platform for pre- and post- analytic specimen processing in demanding laboratory environments.

• share
• favorite_border

AutoSorter™ 1200 is Yaskawa Motoman’s high-speed sorting instrument for pre- and post-analytic specimen processing. It can process up to 1,200 tubes/hr. A large sort deck area yields extended walkaway times and expanded deck configuration options, while its reduced footprint saves lab floorspace.

• share
• favorite_border

Participation Announcement